Novel and Re-emerging Respiratory Viral Diseases (eBook)
174 Seiten
Wiley (Verlag)
978-0-470-77068-9 (ISBN)
This book critically evaluates the latest scientific evidence on novel or re-emerging viral diseases and brings together contributions from world experts on this topic, explaining best practice in their area, and discussing lessons learned and how best to collaborate to prevent and control future outbreaks.
Topics covered include:
- the latest advances in virology, particularly in the area of epidemiology
- diagnostics
- animal models for viral infection
- antiviral and vaccine development
Novel and Re-emerging Respiratory Viral Diseases offers a comprehensive and interdisciplinary account of all aspects of the topic, from basic molecular biology to public health issues, and is therefore essential reading for virologists, infectious disease specialists, public health managers, researchers and epidemiologists, as well as those working in vaccine development, pharmaceutical medicine and drug discovery
The Novartis Foundation is an international scientific and educational charity which promotes the study and general knowledge of science and in particular encourages international co-operation in scientific research.
Chairman: Robert G Webster, St. Jude Children's?Research Hospital, Memphis, USA.
The past decade has seen mounting global concern regarding viral outbreaks such as SARS, avian influenza and West Nile virus. In 2004 and 2005, reports of bird-to-human, and possible human-to-human, transmissions of the H5N1 influenza viruses raised fears that these viruses could cause a pandemic on the scale of the Spanish flu pandemic of 1918. Previous to this, a novel coronavirus had been identified as the aetiological agent of the severe acute respiratory syndrome (SARS), a new respiratory viral disease that emerged at the end of 2002 and caused profound disturbances in over 30 countries worldwide in 2003. It is not known whether the SARS coronavirus will re-emerge, especially since its origins and potential reservoir(s) are unresolved. However, these outbreaks have shown that these viruses can emerge in any part of the world at any time. This book critically evaluates the latest scientific evidence on novel or re-emerging viral diseases and brings together contributions from world experts on this topic, explaining best practice in their area, and discussing lessons learned and how best to collaborate to prevent and control future outbreaks. Topics covered include: the latest advances in virology, particularly in the area of epidemiology diagnostics animal models for viral infection antiviral and vaccine development Novel and Re-emerging Respiratory Viral Diseases offers a comprehensive and interdisciplinary account of all aspects of the topic, from basic molecular biology to public health issues, and is therefore essential reading for virologists, infectious disease specialists, public health managers, researchers and epidemiologists, as well as those working in vaccine development, pharmaceutical medicine and drug discovery
The Novartis Foundation is an international scientific and educational charity which promotes the study and general knowledge of science and in particular encourages international co-operation in scientific research. Chairman: Robert G Webster, St. Jude Children's?Research Hospital, Memphis, USA.
Symposium on Novel and re-emerging respiratory viral diseases,
held at the Institute of Molecular and Cell Biolog y, Singapore,
23-25 April 2007.
Editors: Gregory Bock (Organizer) and Jamie Goode.
This meeting was based on a proposal made by Yee-Joo Tan and
Wanjin Hong.
Robert G. Webster Chair's introduction.
Larry J. Anderson and Suxiang Tong Identification
and characterization of novel viruses.
Discussion.
Edward C. Holmes The evolution of viral emergence.
Discussion.
Derek J. Smith, Jan C. de Jong, Alan S. Lapedes, Terry C.
Jones, Colin A. Russell, Theo M. Bestebroer, Guus F. Rimmelzwaan,
Albert D. M. E. Osterhaus and Ron A. M. Fouchier
Antigenic artography of human and swine influenza A (H3N2)
viruses.
Discussion.
Gabriele Neumann and Yoshihiro Kawaoka Infl uenza
pandemics and control.
Discussion.
J. J. Skehel, S. Wharton, L. Calder and D. Stevens
On the activation of membrane fusion by influenza
haemagglutinin.
Discussion.
Yee Sin Leo Singapore SARS experience and preparation for
future outbreak.
Discussion.
Yee-Joo Tan SARS lessons for a young virology laboratory
in Singapore.
Discussion.
Ih-Jen Su How the SARS experience has helped preparations
for future outbreaks: the Taiwan experience, with emphasis on the
successful control of institutional outbreak of influenza in
2003/2004 using a stockpile of antivirals.
Discussion.
General discussion I.
Yuelong Shu, Yu Lan, Leying Wen, Ye Zhang, Jie Dong, Xinsheng
Zhao, Dayan Wang, Lihong Yao, Xiyan Li, Wei Wang, Xiuping Wang, Qi
Wang, Shumin Duan, Jingjing Huang, Lei Yang, Hongjie Yu, Yuanji
Guo, Weizhong Yang, Xiyan Xu, Nancy J. Cox, Xiaoping Dong, Yu
Wang and Dexin Li Genetic and antigenic characterization
of avian influenza A (H5N1) viruses isolated from humans in
Mainland China.
Discussion.
J. S. M. Peiris and Y. Guan Emerging infectious
diseases and the animal-human interface.
Discussion.
Erich Hoffmann, Hui-Ling Yen, Rachelle Salomon, Neziha
Yilmaz and Robert G. Webster Transmission and
pathogenicity of H5N1 influenza viruses.
Discussion.
John M. Wood Development of vaccine for a future
influenza pandemic.
Discussion.
Final discussion.
Index of contributors.
Subject index.
"This is a valuable account of how new viral pathogens are discovered and analyzed. It also describes how a highly infectious outbreak can be contained. This information will be invaluable in future outbreaks. This book is highly recommended for individuals involved in diagnosing and containing infectious viral diseases." (Doody's, January 2009)
| Erscheint lt. Verlag | 30.4.2008 |
|---|---|
| Reihe/Serie | Novartis Foundation Symposium |
| Sprache | englisch |
| Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Pneumologie |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Mikrobiologie / Infektologie / Reisemedizin | |
| Naturwissenschaften ► Biologie ► Mikrobiologie / Immunologie | |
| Technik | |
| Schlagworte | Biowissenschaften • clinical microbiology • Gesundheits- u. Sozialwesen • Health & Social Care • International Public Health • Klinische Mikrobiologie • Life Sciences • Medical Science • Medical Statistics & Epidemiology • Medizin • Medizinische Statistik u. Epidemiologie • Microbiology & Virology • Mikrobiologie • Mikrobiologie u. Virologie • Public Health • Public Health / International • Statistics • Statistik • Virologie |
| ISBN-10 | 0-470-77068-6 / 0470770686 |
| ISBN-13 | 978-0-470-77068-9 / 9780470770689 |
| Haben Sie eine Frage zum Produkt? |
PDF (Adobe DRM)Größe: 7,1 MB
Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine
Geräteliste und zusätzliche Hinweise
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich
